Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway (Q50459301)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 September 2014

Language	Label	Description	Also known as
English	Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway	scientific article published on 28 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

1 reference

based on heuristic

inferred from title

author name string

Zhiguo Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Shudong Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Shanshan Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Xiaoqing Yan

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yonggang Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Jing Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Nicholas Mellen

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Maiying Kong

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Junlian Gu

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yi Tan

10

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Yang Zheng

11

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Lu Cai

12

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

publication date

28 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

77

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

42-52

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

New type of cardiomyopathy associated with diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Management of cellular energy by the AMP-activated protein kinase system

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Autophagy regulates lipid metabolism

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Regulation of myocardial triacylglycerol synthesis and metabolism

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

New insights into insulin resistance in the diabetic heart

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

The role of AMP-activated protein kinase in mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Deconstructing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Kidney involvement in a nongenetic rat model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Validation of volume-pressure recording tail-cuff blood pressure measurements

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Magnolia extract (BL153) protection of heart from lipid accumulation caused cardiac oxidative damage, inflammation, and cell death in high-fat diet fed mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Metformin use and mortality in ambulatory patients with diabetes and heart failure

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

AMPK signalling and the control of substrate use in the heart

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

The MAP1-LC3 conjugation system is involved in lipid droplet formation

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

ULK1 plays a critical role in AMPK-mediated myocardial autophagy and contractile dysfunction following acute alcohol challenge

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Malonyl CoA control of fatty acid oxidation in the diabetic rat heart.

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Role of malonyl-CoA in heart disease and the hypothalamic control of obesity

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Nitric oxide and mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein tra

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2014.09.022

7 January 2021

Identifiers

10.1016/J.YJMCC.2014.09.022

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/25268649

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50459301&oldid=2249855996"